Protective effect of gallic acid on alloxan-induced oxidative stress and osmotic fragility in rats

Human and Experimental Toxicology

Volumn 33, Issue 6, 2014, Pages 638-649

  Ramkumar, K M ^a   Vijayakumar, R S ^b   Vanitha, P ^a   Suganya, N ^a   Manjula, C ^c   Rajaguru, P ^c   Sivasubramanian, S ^d   Gunasekaran, P ^d  

^a SRM INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c ANNA UNIVERSITY   (India)

^d King Institute of Preventive Medicine and Research   (India)

Author keywords

alloxan; antioxidants; Diabetes; gallic acid; oxidative stress; RBCs

Indexed keywords

CATALASE; GALLIC ACID; GLIBENCLAMIDE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INSULIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ALLOXAN; ANTIDIABETIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE MEMBRANE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; KIDNEY PARENCHYMA; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OSMOTIC FRAGILITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; CELL PROTECTION; CHEMICALLY INDUCED; COMPARATIVE STUDY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ENZYMOLOGY; HEMOLYSIS; KIDNEY; METABOLISM; TIME; WISTAR RAT;

ALLOXAN; ANIMALS; ANTIOXIDANTS; BIOMARKERS; BLOOD GLUCOSE; CATALASE; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTE MEMBRANE; GALLIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLYBURIDE; HEMOLYSIS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; OSMOTIC FRAGILITY; OXIDATIVE STRESS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 84901442858     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327113504792     Document Type: Article

References (66)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011 ; 94: 311-321
2. Mahgoub MA, Abd-Elfattah AS. Diabetes mellitus and cardiac function. Mol Cell Biochem. 1998 ; 180: 59-64 (Pubitemid 28118804)
3. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991 ; 40: 405-412
4. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000 ; 49: 27-29 (Pubitemid 30091790)
5. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002 ; 5: 561-568 (Pubitemid 40684653)
6. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int. 2004 ; 65: 1170-1179 (Pubitemid 38406955)
7. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005 ; 54: 1615-1625 (Pubitemid 40770750)
8. Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes. 2005 ; 54 (Suppl 2). S97 - S107
9. Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med. 1996 ; 20: 463-466 (Pubitemid 26077870)
10. McMillan DE, Utterback NG, La Puma J. Reduced erythrocyte deformability in diabetes. Diabetes. 1978 ; 27: 895-901 (Pubitemid 9023045)
11. Gulcin I, Buyukokuroglu ME, Oktay M, Kufrevioglu OI. Antioxidant and analgesic activities of turpentine of Pinus nigra Arn. subsp. pallsiana (Lamb.) Holmboe. J Ethnopharmacol. 2003 ; 86: 51-58 (Pubitemid 36398658)
12. Phillipson JD. Phytochemistry and medicinal plants. Phytochemistry. 2001 ; 56: 237-243 (Pubitemid 32162796)
13. Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002 ; 81: 81-100 (Pubitemid 34518472)
14. Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal plants. Acta Pol Pharm. 2010 ; 67: 113-118
15. Gori M, Campbell RK. Natural products and diabetes treatment. Diabetes Educ. 1998 ; 24: 201 205-202 208
16. Prabhakar PK, Doble M. Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin J Integr Med. 2011 ; 17: 563-574
17. Konishi Y, Zhao Z, Shimizu M. Phenolic acids are absorbed from the rat stomach with different absorption rates. J Agric Food Chem. 2006 ; 54: 7539-7543 (Pubitemid 44645769)
18. Inoue M, Suzuki R, Koide T, Sakaguchi N, Ogihara Y, Yabu Y. Antioxidant, gallic acid, induces apoptosis in HL-60RG cells. Biochem Biophys Res Commun. 1994 ; 204: 898-904 (Pubitemid 24344005)
19. Inoue M, Sakaguchi N, Isuzugawa K, Tani H, Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull. 2000 ; 23: 1153-1157
20. Kim YJ. Antimelanogenic and antioxidant properties of gallic acid. Biol Pharm Bull. 2007 ; 30: 1052-1055
21. Faried A, Kurnia D, Faried LS, Usman N, Miyazaki T, Kato H, et al. Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol. 2007 ; 30: 605-613
22. Haslam E, Cai Y. Plant polyphenols (vegetable tannins): gallic acid metabolism. Nat Prod Rep. 1994 ; 11: 41-66
23. Priscilla DH, Prince PS. Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. Chem Biol Interact. 2009 ; 179: 118-124
24. Shahrzad S, Aoyagi K, Winter A, Koyama A, Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr. 2001 ; 131: 1207-1210 (Pubitemid 32275101)
25. Rajalakshmi K, Devaraj H, Niranjali Devaraj S. Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice. Food Chem Toxicol. 2001 ; 39: 919-922 (Pubitemid 32728332)
26. Soto C, Muriel P, Reyes JL. Pancreatic lipid peroxidation in alloxan-induced diabetes mellitus. Arch Med Res. 1994 ; 25: 377-380
27. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008 ; 51: 216-226
28. Punithavathi VR, Stanely Mainzen Prince P, Kumar MR, Selvakumari CJ. Protective effects of gallic acid on hepatic lipid peroxide metabolism, glycoprotein components and lipids in streptozotocin-induced type II diabetic Wistar rats. J Biochem Mol Toxicol. 2011 ; 25: 68-76
29. Arokiyaraj S, Balamurugan R, Augustian P. Antihyperglycemic effect of Hypericum perforatum ethyl acetate extract on streptozotocin-induced diabetic rats. Asian Pac J Trop Biomed. 2011 ; 1: 386-390
30. Cramp DG. New automated method for measuring glucose by glucose oxidase. J Clin Pathol. 1967 ; 20: 910-912
31. Crowe SM, Mastrobattista JM, Monga M. Oral glucose tolerance test and the preparatory diet. Am J Obstet Gynecol. 2000 ; 182: 1052-1054 (Pubitemid 30353278)
32. Niehaus WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968 ; 6: 126-130
33. Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972 ; 47: 389-394
34. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984 ; 21: 130-132 (Pubitemid 15207169)
35. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 1973 ; 179: 588-590
36. Ellman GL, Gan GL. Erythrocyte glutathione-levels in patients of a mental hospital. Nature. 1964 ; (202). 904
37. Beutler E, Kuhl W, West C. The osmotic fragility of erythrocytes after prolonged liquid storage and after reinfusion. Blood. 1982 ; 59: 1141-1147 (Pubitemid 12074839)
38. Cynamon HA, Isenberg JN, Nguyen CH. Erythrocyte malondialdehyde release in vitro: a functional measure of vitamin E status. Clin Chim Acta. 1985 ; 151: 169-176 (Pubitemid 15248324)
39. Pal SK, Shukla Y. Herbal medicine: current status and the future. Asian Pac J Cancer Prev. 2003 ; 4: 281-288
40. Xiao J, Kai G. A review of dietary polyphenol-plasma protein interactions: characterization, influence on the bioactivity, and structure-affinity relationship. Crit Rev Food Sci Nutr. 2012 ; 52: 85-101
41. Butler MS. Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008 ; 25: 475-516 (Pubitemid 351725315)
42. Ow YY, Stupans I. Gallic acid and gallic acid derivatives: effects on drug metabolizing enzymes. Curr Drug Metab. 2003 ; 4: 241-248 (Pubitemid 36656481)
43. Hodgson JM, Morton LW, Puddey IB, Beilin LJ, Croft KD. Gallic acid metabolites are markers of black tea intake in humans. J Agric Food Chem. 2000 ; 48: 2276-2280 (Pubitemid 30431226)
44. Patel SS, Goyal RK. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res. 2011 ; 3: 239-245
45. Schwartz RS, Madsen JW, Rybicki AC, Nagel RL. Oxidation of spectrin and deformability defects in diabetic erythrocytes. Diabetes. 1991 ; 40: 701-708
46. Christopher MM. Hematologic complications of diabetes mellitus. Vet Clin North Am Small Anim Pract. 1995 ; 25: 625-637
47. Adewoye EO, Akinlade KS, Olorunsogo OO. Erythrocyte membrane protein alteration in diabetics. East Afr Med J. 2001 ; 78: 438-440
48. Richter C. Biophysical consequences of lipid peroxidation in membranes. Chem Phys Lipids. 1987 ; 44: 175-189 (Pubitemid 17157977)
49. Vahalkar GS, Haldankar VA. RBC membrane composition in insulin dependent diabetes mellitus in context of oxidative stress. Indian J Clin Biochem. 2008 ; 23: 223-226
50. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J. 2012 ; 12: 5-18
51. Newsholme P, Haber EP, Hirabara SM, Rebelato EL, Procopio J, Morgan D, et al. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol. 2007 ; 583: 9-24 (Pubitemid 47244241)
52. Saba AB, Oyagbemi AA, Azeez OI. Antidiabetic and haematinic effects of Parquetina nigrescens on alloxan induced type-1 diabetes and normocytic normochromic anaemia in Wistar rats. Afr Health Sci. 2010 ; 10: 276-282
53. Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, Matsuhisa M, et al. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid Redox Signal. 2007 ; 9: 355-366 (Pubitemid 46145981)
54. Santos GJ, Oliveira CA, Boschero AC, Rezende LF. CNTF protects MIN6 cells against apoptosis induced by Alloxan and IL-1beta through downregulation of the AMPK pathway. Cell Signal. 2011 ; 23: 1669-1676
55. Ramkumar KM, Lee AS, Krishnamurthi K, Devi SS, Chakrabarti T, Kang KP, et al. Gymnema montanum H. protects against alloxan-induced oxidative stress and apoptosis in pancreatic beta-cells. Cell Physiol Biochem. 2009 ; 24: 429-440
56. Latha M, Pari L, Ramkumar KM, Rajaguru P, Suresh T, Dhanabal T, et al. Antidiabetic effects of scoparic acid D isolated from Scoparia dulcis in rats with streptozotocin-induced diabetes. Nat Prod Res. 2009 ; 23: 1528-1540
57. Yang H, Jin X, Kei Lam CW, Yan SK. Oxidative stress and diabetes mellitus. Clin Chem Lab Med. 2011 ; 49: 1773-1782
58. Takayanagi R, Inoguchi T, Ohnaka K. Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus. J Clin Biochem Nutr. 2011 ; 48: 72-77
59. Osterode W, Holler C, Ulberth F. Nutritional antioxidants, red cell membrane fluidity and blood viscosity in type 1 (insulin dependent) diabetes mellitus. Diabet Med. 1996 ; 13: 1044-1050 (Pubitemid 26420065)
60. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 1990 ; 15: 129-135 (Pubitemid 20186835)
61. Winterbourn CC. Superoxide as an intracellular radical sink. Free Radic Biol Med. 1993 ; 14: 85-90 (Pubitemid 23024261)
62. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother. 2003 ; 57: 145-155 (Pubitemid 36740460)
63. Jain SK. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J Biol Chem. 1989 ; 264: 21340-21345 (Pubitemid 20017957)
64. Hill MA, Court JM. Erythrocyte membrane fluidity in type 1 diabetes mellitus. Pathology. 1983 ; 15: 449-451 (Pubitemid 14185707)
65. Matteucci E, Giampietro O. Oxidative stress in families of type 1 diabetic patients. Diabetes Care. 2000 ; 23: 1182-1186 (Pubitemid 30616810)
66. Jain SK, McVie R, Duett J, Herbst JJ. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes. 1989 ; 38: 1539-1543 (Pubitemid 20006678)